Regarding the pro-inflammatory profile, our analysis of C-reactive protein is in accordance with Kumar et al., who actually suggested to use high-sensitivity C-reactive protein as a surrogate marker of NAFLD’s severity [25]. The gene discussed is CRP; the disease is metabolic dysfunction-associated steatotic liver disease.